Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.
Chan-Young JungHyung Woo KimJoung Il LeeHyun Woong LeeSang Hoon AhnSeung-Up KimBeom Seok KimPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
TAF and BSV showed a similar risk of kidney function decline in patients with treatment-naïve CHB. Further prospective randomized studies are warranted for validation.